Boston Scientific Liberty Stent Groomed To Face Next-Gen Cobalt Competitors

Boston Scientific will enroll approximately 400 patients in an ongoing clinical trial to support a PMA supplement for the firm's Taxus Liberty stent platform

More from Archive

More from Medtech Insight